These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2016-000097-38 Randomized, double-blind, placebo-controlled study to measure 2L®ALERG (homeopathic drug) efficacy on symptoms of allergic rhinitis and allergic rhinoconjunctivitis in patients with a seasonal allergy... not-yet-due
Ongoing 2019-001085-15 Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infections. Étude randomisée, contrôlée contre placebo, en double ... not-yet-due
Ongoing 2019-001443-52 Randomized study to evaluate 2LVERU® JUNIOR and 2LVERU® efficacy on the treatment of warts. Protocol EVAsION Etude randomisée pour évaluer l’efficacité du 2LVERU® JUNIOR et du 2LVERU® sur le traite... not-yet-due
Completed, report not yet due Terminated 2019-001572-11 Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent genital herpes infections. Étude randomisée, contrôlée contre placebo, en double av... 2023-04-18 not-yet-due
No trial status on register 2020-000085-42 Randomized, placebo-controlled, double blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection. EBVAST Study bad-data